LeapFrog leads $61m investment in India's Redcliffe Lifetech

Healthcare-focused Healthquad and Alkemi Growth Capital also participated, as did Schroders, LC Nueva Investment Partners, Growth Spark Ventures, and Chiratae Ventures.

Redcliffe provides on-demand one-hour home collection and same-day reporting for routine and specialised diagnostic tests supported by 22 labs across 14 cities. The company describes the model as omnichannel, combining online channels with a network of 400 phlebotomists in 100 cities and 500 collections centres.

Additional offerings include a live, remote temperature tracking service to monitor the samples collected by phlebotomists. The service, said to be the first of its kind, aims to ensure the samples maintain adequate temperature to meet quality and safety standards.

There is a strong emphasis on mass-market accessibility through technology, non-communicable diseases known to kill more than 6m Indians a year. Prices are said to be 25-60% lower than traditional competitors. The plan is to have 500m users within five years by expanding into lower-tier cities, including tier-IV cities, which can have populations as low as 10,000.

“Redcliffe operates at the intersection of healthcare and technology, developing innovative solutions that address persistent challenges in the Indian market. It has built a proprietary technology platform for outstanding consumer experience also enabling scaling of its operations at their labs, fulfilment and overall CRM [customer relationship management],” Ranjith Menon, a partner at Chiratae, said in a statement.

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Save this article  
• Send to  

• Topics
• South Asia
• Healthcare
• Expansion
• India
• LeapFrog Investments
• HealthQuad
• Alkemi Growth Capital
• Chiratae Ventures